Literature DB >> 11880025

Carcinoid heart disease: a case report and literature review.

Monica Botero1, Ralph Fuchs, David A Paulus, D Scott Lind.   

Abstract

We report a patient who presented for elective exploratory laparotomy, and resection of a pelvic mass, which was thought to be ovarian carcinoma. Intraoperative transesophageal echocardiography demonstrated right-sided valvular heart lesions, which suggested the diagnosis of carcinoid syndrome before a pathologic confirmation was obtained. This article discusses the classical presentation and anesthetic management of patients with carcinoid syndrome and emphasizes the importance of proper preoperative diagnosis and careful planning if the incidence and severity of the symptoms that this condition can provoke are to be reduced.

Entities:  

Mesh:

Year:  2002        PMID: 11880025     DOI: 10.1016/s0952-8180(01)00353-1

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  3 in total

1.  Primary insular carcinoid of the ovary with carcinoid heart disease: Unfavourable outcome of a case.

Authors:  Alessandro Buda; Daniela Giuliani; Nicola Montano; Patrizia Perego; Rodolfo Milani
Journal:  Int J Surg Case Rep       Date:  2011-11-07

2.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.

Authors:  Gregory Kaltsas; Martyn Caplin; Philippa Davies; Diego Ferone; Rocio Garcia-Carbonero; Simona Grozinsky-Glasberg; Dieter Hörsch; Eva Tiensuu Janson; Reza Kianmanesh; Beata Kos-Kudla; Marianne Pavel; Anja Rinke; Massimo Falconi; Wouter W de Herder
Journal:  Neuroendocrinology       Date:  2017-03-02       Impact factor: 4.914

3.  Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery.

Authors:  Myrtille Fouché; Yves Bouffard; Mary-Charlotte Le Goff; Johanne Prothet; François Malavieille; Pierre Sagnard; Françoise Christin; Davy Hayi-Slayman; Arnaud Pasquer; Gilles Poncet; Thomas Walter; Thomas Rimmelé
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.